SEC Company Response from ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221) (ARTL) — Jun 20, 2019
ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221)
Date: June 20, 2019 · CIK: 0001621221 · Accession: 0001640334-19-001183
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230658
Letter
Re:
artl_corresp.htmJune 20, 2019
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attn:
Charlie Guidry
Artelo Biosciences, Inc.
Registration Statement on Form S-1, as amended (File No. 333-230658)
Ladies and Gentlemen:
As the underwriter of the proposed offering of Artelo Biosciences, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:00 p.m., Eastern Time, on June 20, 2019, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectuses through the date hereof:
Preliminary Prospectuses dated May 31, 2019:
Copies to underwriters: 2
Copies to prospective dealers: 5
Copies to prospective institutional investors: 65
Copies to prospective retail investors: 389
Preliminary Prospectuses dated June 10, 2019:
Copies to underwriters: 2
Copies to prospective dealers: 6
Copies to prospective institutional investors: 72
Copies to prospective retail investors: 592
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Maxim Group LLC
Show Raw Text
CORRESP 1 filename1.htm artl_corresp.htmJune 20, 2019 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attn: Charlie Guidry Re: Artelo Biosciences, Inc. Registration Statement on Form S-1, as amended (File No. 333-230658) Ladies and Gentlemen: As the underwriter of the proposed offering of Artelo Biosciences, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:00 p.m., Eastern Time, on June 20, 2019, or as soon thereafter as is practicable. Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectuses through the date hereof: Preliminary Prospectuses dated May 31, 2019: Copies to underwriters: 2 Copies to prospective dealers: 5 Copies to prospective institutional investors: 65 Copies to prospective retail investors: 389 Preliminary Prospectuses dated June 10, 2019: Copies to underwriters: 2 Copies to prospective dealers: 6 Copies to prospective institutional investors: 72 Copies to prospective retail investors: 592 The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, Maxim Group LLC By: /s/ Clifford A. Teller Name: Clifford A. Teller Title: Head of Investment Banking, Executive Managing Director